Jean-Charles Chevalier

C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes.

NIO is a pioneer and a leading company in the premium smart electric vehicle market. Founded in November 2014, NIO’s mission is to shape a sustainable and brighter future together. NIO aims to build a community starting with smart electric vehicles to share joy and grow together with users. NIO designs, develops, jointly manufactures and sells premium smart electric vehicles, driving innovations in next-generation technologies in autonomous driving, digital technologies, electric powertrains and batteries. NIO differentiates itself through its continuous technological breakthroughs and innovations, such as its industry-leading battery swapping technologies, Battery as a Service, or BaaS, as well as its proprietary autonomous driving technologies and Autonomous Driving as a Service, or ADaaS. NIO’s models for sale include the all-new smart electric flagship SUV ES8, the smart electric flagship coupe SUV EC7, the smart electric mid-large SUV ES7, the smart electric flagship sedan ET7, the all-new smart electric all-round SUV ES6, the all-new smart electric coupe SUV EC6, the smart electric mid-sized sedan ET5, and the smart electric tourer ET5T.

Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens. With Dassault Systèmes’ 3DEXPERIENCE platform, 370,000 customers of all sizes, in all industries, can collaborate, imagine and create sustainable innovations that drive meaningful impact. For more information, visit: https://www.3ds.com

Entrepreneurship in the service of the climate emergency! We identify, fund, and launch 100 companies designed and structured from start to finish to combat greenhouse gases. Our mission: > identify high-impact innovations; > recruit experienced entrepreneurs to transform these innovations into companies with solid business models; > inject financial resources to maximize and accelerate deployment. All innovations are made available as open source. Every euro raised is used to combat climate change. Any individual or organization can join the effort starting at €1 on our website (in just a few minutes) and take concrete action, on a global scale, against climate change. Everything is detailed (and you can contact us) at team-planet.com

Our storied and iconic brands embody the passion of their visionary founders and today’s customers in their innovative products and services: they include Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep®, Lancia, Maserati, Opel, Peugeot, Ram, Vauxhall and mobility brands Free2move and Leasys. Powered by our diversity, we lead the way the world moves – aspiring to become the greatest sustainable mobility tech company, not the biggest, while creating added value for all stakeholders as well as the communities in which we operate.

Based in New York City, Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Building on groundbreaking research from Weill Cornell Medicine and the University of California San Diego, Lexeo partners with preeminent institutions on the cutting edge of gene therapy research. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4 associated Alzheimers disease programs, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing and commercialization. For more information, please visit www.lexeotx.com.

Euroholdings Ltd. (the "Company"), was incorporated on March 20, 2024 under the laws of the Republic of the Marshall Islands. The Company was incorporated by Euroseas Ltd. (NASDAQ: ESEA, or "Euroseas") to serve as the holding company of three subsidiaries that were spun-off by Euroseas to Euroholdings on March 18, 2025. Euroholdings Ltd. is a provider of worldwide ocean-going transportation services. The Company’s operations are managed by Eurobulk Ltd. an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The Company has a fleet of 2 feeder containership vessels with a cargo capacity of 40,882 dwt, or 3,171 teu. Euroholdings is listed on the Nasdaq Capital Market under the symbol “EHLD”.

IHG Hotels & Resorts [LON:IHG, NYSE:IHG (ADRs)] is a global hospitality company, with a purpose to provide True Hospitality for Good. With a family of 20 hotel brands and IHG One Rewards, one of the worlds largest hotel loyalty programmes, IHG has over 6,900 open hotels in more than 100 countries, and a development pipeline of over 2,000 properties. Luxury & Lifestyle: Six Senses Hotels Resorts Spas, Regent Hotels & Resorts, InterContinental Hotels & Resorts, Vignette Collection, Kimpton Hotels & Restaurants, Hotel Indigo Premium: voco hotels, HUALUXE Hotels & Resorts, Crowne Plaza Hotels & Resorts, EVEN Hotels Essentials: Holiday Inn Express, Holiday Inn Hotels & Resorts, Garner hotels, avid hotels Suites: Atwell Suites, Staybridge Suites, Holiday Inn Club Vacations, Candlewood Suites Exclusive Partners: Iberostar Beachfront Resorts InterContinental Hotels Group PLC is the Groups holding company and is incorporated and registered in England and Wales. Approximately 400,000 people work across IHGs hotels and corporate offices globally. Visit us online for more about our hotels and reservations and IHG One Rewards. To download the IHG One Rewards app, visit the Apple App or Google Play stores.

Headquartered in New York City, Take-Two Interactive Software, Inc. is a leading developer, publisher, and marketer of interactive entertainment for consumers around the globe. We develop and publish products principally through Rockstar Games, 2K, and Zynga. Our strategy is to create hit entertainment experiences, delivered on every platform relevant to our audience through a variety of sound business models. Our pillars - creativity, innovation, and efficiency - guide us as we strive to create the highest quality, most captivating experiences for our consumers. The Company’s common stock is publicly traded on NASDAQ under the symbol TTWO. For more corporate and product information please visit our website at http://www.take2games.com.

Investissez dans des obligations immobilières dès 10€ et recevez des intérêts tous les mois. Cest possible grâce à Bricks.co Nous identifions des porteurs de projets et facilitons le financement de leurs initiatives immobilières grâce à notre communauté. Bricks.co Start Small, Think Big !

C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes.

Vivoryon is a clinical stage biotechnology company focused on developing innovative small molecule-based medicines for the treatment of inflammatory and fibrotic disorders of the kidney. Driven by its passion for ground-breaking science and innovation, the Company strives to improve patient outcomes by changing the course of severe diseases through modulating the activity and stability of pathologically relevant proteins. Vivoryon’s most advanced program, varoglutamstat, a proprietary, first-in-class orally available QPCT/L inhibitor, is being evaluated to treat diabetic kidney disease.

NIO is a pioneer and a leading company in the premium smart electric vehicle market. Founded in November 2014, NIO’s mission is to shape a sustainable and brighter future together. NIO aims to build a community starting with smart electric vehicles to share joy and grow together with users. NIO designs, develops, jointly manufactures and sells premium smart electric vehicles, driving innovations in next-generation technologies in autonomous driving, digital technologies, electric powertrains and batteries. NIO differentiates itself through its continuous technological breakthroughs and innovations, such as its industry-leading battery swapping technologies, Battery as a Service, or BaaS, as well as its proprietary autonomous driving technologies and Autonomous Driving as a Service, or ADaaS. NIO’s models for sale include the all-new smart electric flagship SUV ES8, the smart electric flagship coupe SUV EC7, the smart electric mid-large SUV ES7, the smart electric flagship sedan ET7, the all-new smart electric all-round SUV ES6, the all-new smart electric coupe SUV EC6, the smart electric mid-sized sedan ET5, and the smart electric tourer ET5T.

Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens. With Dassault Systèmes’ 3DEXPERIENCE platform, 370,000 customers of all sizes, in all industries, can collaborate, imagine and create sustainable innovations that drive meaningful impact. For more information, visit: https://www.3ds.com

Entrepreneurship in the service of the climate emergency! We identify, fund, and launch 100 companies designed and structured from start to finish to combat greenhouse gases. Our mission: > identify high-impact innovations; > recruit experienced entrepreneurs to transform these innovations into companies with solid business models; > inject financial resources to maximize and accelerate deployment. All innovations are made available as open source. Every euro raised is used to combat climate change. Any individual or organization can join the effort starting at €1 on our website (in just a few minutes) and take concrete action, on a global scale, against climate change. Everything is detailed (and you can contact us) at team-planet.com